What Dermatologists Wish GLP-1 Patients Knew
Your skin, hair, and face change during rapid weight loss. Here is what dermatologists want GLP-1 patients to know about protecting and caring for their skin.
Medical Disclaimer: This article provides general dermatology information. Consult a board-certified dermatologist for personalized skin care advice.
Rapid weight loss transforms your body, and your skin has to keep up. Dermatologists who see semaglutide and tirzepatide patients have specific advice for protecting skin health during your weight loss journey.
1. "Ozempic Face" Is Weight Loss Face
The media calls it "Ozempic face," but dermatologists point out that facial volume loss happens with any significant weight loss. The face is one of the first and most visible places fat is lost. For those losing 30+ pounds, facial changes can be dramatic, making you look older or more gaunt. Options include dermal fillers, facial fat grafting, or simply accepting the natural change.
2. Start Skin Care Before You Need It
Do not wait until you see loose skin to start protecting your skin. From day one:
- Retinol/retinoid: Boosts collagen production and skin turnover. Start with OTC retinol and progress to prescription if tolerated
- Vitamin C serum: Antioxidant that supports collagen synthesis
- Sunscreen daily: UV damage destroys collagen and elastin
- Hydration: Inside (water) and outside (moisturizer)
- Collagen supplements: 10-15g daily may support skin elasticity (evidence is moderate but growing)
3. Hair Loss Is Temporary but Real
Hair loss on GLP-1 (telogen effluvium) typically starts 2-4 months after beginning treatment and resolves within 6-12 months. Dermatologists recommend adequate protein, biotin, iron screening, and patience. It is not permanent.
4. Expect Skin Changes
Weight loss and hormonal shifts can cause temporary skin changes including new breakouts, changes in skin texture, skin tags (may shrink or fall off), improved rosacea in some patients, and changes in sweating patterns.
5. Know Your Options for Loose Skin
For patients losing 50+ pounds, some degree of loose skin is common. Non-surgical options include radiofrequency treatments, ultrasound therapy, and laser treatments. Surgical options include body contouring surgery (abdominoplasty, brachioplasty, etc.). Most surgeons recommend waiting until weight is stable for 6-12 months before considering surgery.
Frequently Asked Questions
Does GLP-1 cause 'Ozempic face'?
Ozempic face is not caused by the medication itself but by rapid facial fat loss. Everyone loses fat from their face during significant weight loss. It is more noticeable in older patients and those losing large amounts of weight. Dermatologists can offer treatments like dermal fillers to restore facial volume if desired.
How do I prevent loose skin on GLP-1?
There is no guaranteed prevention, but dermatologists recommend: staying hydrated (supports skin elasticity), using retinoid products (boost collagen production), maintaining muscle mass through strength training, losing weight gradually rather than rapidly, and eating adequate protein and vitamin C (collagen building blocks).
Does GLP-1 affect acne?
Weight loss on GLP-1 may improve hormonal acne, especially in women with PCOS. However, some patients report new breakouts during treatment, possibly related to hormonal shifts during rapid weight loss. If acne worsens, consult a dermatologist.
Will my skin sag after losing weight on GLP-1?
Skin elasticity depends on age, genetics, how much weight you lose, and how quickly. Younger patients with less weight to lose typically have better skin redraping. Losing 50+ pounds may result in some loose skin. Dermatologists and plastic surgeons can discuss options if loose skin is a concern.
Look and Feel Your Best
Trimi provides affordable GLP-1 treatment with comprehensive support for your whole health journey.
Get Started TodayMore on Expert Advice
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).